Drug reference

alirocumab

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 48

Overview

Names and pronunciation

(al′-i-rok′-ue-mab) Praluent

PDF page 48

Functional class

Func. class.: Antilipemic

PDF page 48

Uses

USES: Heterozygous, familial hyper- cholesterolemia, atherosclerotic disease

PDF page 48

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adult: SUBCUT 75 mg q2wk, may in- crease to 150 mg q2wk if needed after 4-8 wk or 300 mg q4wk

PDF page 48

Available forms

Available forms: Injection: 75 mg/mL, 150 mg/mL (single-dose pens/syringes)

PDF page 48

Dose text by age group

Adult

• Adult: SUBCUT 75 mg q2wk, may in- crease to 150 mg q2wk if needed after 4-8 wk or 300 mg q4wk

PDF page 48

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

alirocumab

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 48

Overview

Names and pronunciation

(al′-i-rok′-ue-mab) Praluent

PDF page 48

Functional class

Func. class.: Antilipemic

PDF page 48

Uses

USES: Heterozygous, familial hyper- cholesterolemia, atherosclerotic disease

PDF page 48

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adult: SUBCUT 75 mg q2wk, may in- crease to 150 mg q2wk if needed after 4-8 wk or 300 mg q4wk

PDF page 48

Available forms

Available forms: Injection: 75 mg/mL, 150 mg/mL (single-dose pens/syringes)

PDF page 48

Dose text by age group

Adult

• Adult: SUBCUT 75 mg q2wk, may in- crease to 150 mg q2wk if needed after 4-8 wk or 300 mg q4wk

PDF page 48

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.